We see Z4D.SI stock plunge 25.00% to S$0.009 in pre-market trade on 06 Mar 2026. The move follows extremely thin liquidity with 6,000 shares traded versus an average of 503,200. Traders should note the stock trades on the SES (Singapore) and carries a tiny market cap of S$1,447,222. Early action looks driven by low volume and weak fundamentals, making careful position sizing critical in the pre-market session.

Z4D.SI stock pre-market drop and key metrics

Z4D.SI stock opened at S$0.009 and matched the day low and high at S$0.009. The previous close was S$0.012, so today’s change is -S$0.003 or -25.00%. Volume is 6,000 compared with an average volume of 503,200, highlighting extreme illiquidity. Reported EPS is -0.01 and reported PE is -0.90, reflecting negative earnings. Year range runs from S$0.006 to S$0.016.

What likely triggered the sell-off

The sell-off appears structural, not news-driven. There are no company press releases today and recent public news is sparse. Thin float and low free-float liquidity amplify selling pressure when even small orders hit the market. Healthcare sector peers show mixed results and the sector YTD is down -6.76%, which provides a cautious backdrop. For comparative data see recent coverage Investing.com competitor compare 1 and Investing.com competitor compare 2.

Meyka stock grade and technical snapshot for Z4D.SI stock

Meyka AI rates Z4D.SI with a score out of 100: 66.68/100, Grade B, suggestion HOLD. This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts and analyst consensus. Technicals show RSI 28.59 (oversold) and ADX 36.13 (strong trend). The 50-day average is S$0.01204 and the 200-day average is S$0.00980. These indicators suggest short-term oversold conditions but weak fundamentals.

Valuation, forecasts and price targets for Z4D.SI stock

Valuation is challenged: price-to-sales is 0.83 and book value per share is negative -0.01366. CompanyRating dated 2026-03-05 shows a C rating and a Sell recommendation. Meyka AI’s forecast model projects a monthly level of S$0.010, a yearly level of S$0.03130, and a three-year level of S$0.06724. Based on liquidity and fundamentals we set a short-term price target range: Bear S$0.005, Base S$0.020, Bull S$0.070. Forecasts are model projections and not guarantees.

Risks and catalysts affecting Z4D.SI stock outlook

Key risks include negative operating cash flow per share -0.02350, current ratio 0.52, and negative net income per share -0.02653. The company mixes healthcare services and commodity trading, which increases execution risk. Catalysts could include contract wins for NADORA postpartum services, improved commodity margins, or clearer earnings updates. Note the company is listed on SES in Singapore and reports in SGD.

Pre-market trading strategy for top losers including Z4D.SI stock

We recommend size control and limit orders when trading Z4D.SI stock in pre-market. Avoid market orders given the thin float and wide spreads. Use a tight stop-loss sized to your risk tolerance and watch on-book liquidity before entering. Monitor on-exchange prints and any company announcements. For a quick reference see the Meyka stock page for Z4D.SI: Meyka stock page.

Final Thoughts

Z4D.SI stock is a clear pre-market top loser on 06 Mar 2026, down 25.00% to S$0.009 on extremely light volume. Fundamentals are weak, with EPS -0.01, PE -0.90, negative free cash flow per share -0.02350, and a tight current ratio 0.52. Meyka AI rates Z4D.SI with a score out of 100 at 66.68, Grade B, suggesting a HOLD stance but highlighting risks. Meyka AI’s forecast model projects a one-year level of S$0.03130, implying an upside of 247.74% versus today’s S$0.009. Forecasts are model-based projections and not guarantees. For traders, the primary takeaway is that low liquidity drives volatility. Investors should wait for clearer fundamentals or volume confirmation before adding exposure.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.